AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: Role of the AT1 receptor and NADPH oxidase

Hypertension

Volumn 42, Issue 2, 2003, Pages 206-212

  Privratsky, Jamie R ^a   Wold, Loren E ^a   Sowers, James R ^b   Quinn, Mark T ^c   Ren, Jun ^a,d  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c MONTANA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Angiotensin II; Cardiac function; Cardiomyopathy; Glucose; Oxidases

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; APOCYNIN; CALCIUM ION; DIPHENYLIODONIUM SALT; DODECYL SULFATE SODIUM; GLUCOSE; JANUS KINASE; L 158 809; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ACETOPHENONE DERIVATIVE; ANGIOTENSIN RECEPTOR; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; JAK2 PROTEIN, RAT; JANUS KINASE 2; NEUTROPHIL CYTOSOLIC FACTOR 1; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; TETRAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME SUBUNIT; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; ANIMAL; CELL CULTURE; CYTOLOGY; DIABETIC ANGIOPATHY; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETOPHENONES; ANIMALS; CELLS, CULTURED; DIABETIC ANGIOPATHIES; ENZYME INHIBITORS; GLUCOSE; HEART DISEASES; HEART VENTRICLES; IMIDAZOLES; JANUS KINASE 2; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NADPH OXIDASE; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; SODIUM DODECYL SULFATE; TETRAZOLES;

EID: 0042266230     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000082814.62655.85     Document Type: Article

References (26)

1. Grundy SM, Benjamin IJ, Burke GL, Chaiot A, Eckel RH, Howrda BV, Mitch W, Smith SC, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146.
2. Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy. Cardiovasc Toxicol. 2001;1:181-193.
3. Francis GS. Diabetic cardiomyopathy: fact or fiction? Heart. 2001;85:247-248.
4. Ren J, Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol Heart Circ Physiol. 1997;272:H148-H158.
5. Dutta K, Podolin DA, Davidson MB, Davidoff AJ. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes. 2001;50:1186-1192.
6. Wold LE, Relling DP, Colligan PB, Scott GI, Hintz KK, Ren BH, Epstein PN, Ren J. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes. J Mol Cell Cardiol. 2001;33:1719-1726.
7. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem. 1998;180:53-57.
8. Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37:1047-1052.
9. 1-type angiotensin receptor in oxidative stress and atherogenesis, part I: oxidative stress and atherogenesis. Circulation. 2002;105:393-396.
10. Sowers JR. Hypertension, angiotensin II, and oxidative stress. N Engl J Med. 2002;346:1999-2001.
11. Mascareno E, Siddiqui MA. The role of Jak/STAT signaling in heart tissue renin-angiotensin system. Mol Cell Biochem. 2000;212:171-175.
12. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res. 2001;88:947-953.
13. Schindler C. Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu Rev Biochem. 1995;64:621-651.
14. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000;20:2175-2183.
15. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept. 2000;91:21-27.
16. Ren J, Dominguez LJ, Sowers JR, Davidoff AJ. Metformin but not glyburide prevents high glucose-induced prolonged relaxation in cultured cardiomyocytes. Diabetes. 1999;48:2059-2065.
17. Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-1 attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab. 2002;283:E658-E666.
18. DeLeo FR, Ulman KV, Davis AR, Jutila KL, Quinn MT. Assembly of the human neutrophil NADPH oxidase involves binding of p67phox and flavocytochrome b to a common functional domain in p47phox. J Biol Chem. 1996;271:17013-17020.
19. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens. 2001;19:1245-1254.
20. Meyer JW, Schmitt ME. A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett. 2000;472:1-4.
21. Sasaki J, Hiura M, Yamaguchi M, Sakai M, Aoki K, Abe H, Okamura N, Ishibashi S. Activation mechanism of NADPH oxidase by SDS in intact guinea pig neutrophils. Arch Biochem Biophys. 1994;315:16-23.
22. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes. 2001;50:2363-2375.
23. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D. Acute hyperglycemia induces nitro-tyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002;51:1076-1082.
24. Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes. 1994;43:e1180-e1184.
25. Sodhi CP, Kanwar YS, Sahai A. Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells. Am J Physiol Heart Circ Physiol. 2003;284:H846-H852.
26. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247-250.